SCHEMBL24258519

SCHEMBL24258519

FC(F)c1cc2c(cc1-c1cn[nH]c1)CCCN2

nearest known ligand 0.41

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ PDE3B Q13370 1/20 0.41
▸ PDE3A Q14432 1/20 0.41
▸ ROCK2 O75116 5/20 0.35
▸ ROCK1 Q13464 2/20 0.35
▸ GAA P10253 2/20 0.34
▸ KDM4E B2RXH2 2/20 0.34
▸ MAPT P10636 2/20 0.34
▸ ALDH1A1 P00352 1/20 0.34
▸ LMNA P02545 1/20 0.34
▸ TP53 P04637 1/20 0.34
▸ THRB P10828 1/20 0.34
▸ ALOX15 P16050 1/20 0.34
▸ CASP1 P29466 1/20 0.34
▸ HTT P42858 1/20 0.34
▸ CASP7 P55210 1/20 0.34
▸ HSD17B10 Q99714 1/20 0.34
▸ TDP1 Q9NUW8 1/20 0.34
▸ CREBBP Q92793 5/20 0.32
▸ AR P10275 2/20 0.31
▸ CYP11B2 P19099 1/20 0.31

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL30853471 0.82 MAPT (0.35) GAAKDM4EMAPTALDH1A1LMNA
SCHEMBL23930147 0.82 MAPT (0.35) GAAKDM4EMAPTALDH1A1LMNA
SCHEMBL29403112 0.78 CREBBP (0.50) CREBBPBRD4EP300
SCHEMBL17785637 0.78 CREBBP (0.50) CREBBPBRD4EP300
SCHEMBL21240848 0.76 ATM (0.34) GAAKDM4EMAPTALDH1A1LMNA
SCHEMBL31565516 0.73 MAPT (0.31) GAAKDM4EMAPTALDH1A1LMNA
SCHEMBL31565360 0.73 AR (0.32) GAAKDM4EMAPTALDH1A1LMNA
SCHEMBL30992903 0.73 CREBBP (0.41) PDE3BPDE3AGAAKDM4EMAPT
SCHEMBL23930103 0.72 CREBBP (0.39) CREBBPBRD4EP300
SCHEMBL30023382 0.72 CREBBP (0.39) CREBBPBRD4EP300

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-3464270-B1 HETEROCYCLIC INHIBITORS OF CBP/EP300 AND THEIR USE IN THE TREATMENT OF CANCER GENENTECH INC (US) 2022-02-23 — — EP disclosed
Send feedback